Luís Eduardo Magalhães

ORCID: 0000-0003-4211-6952
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Muscle and Compartmental Disorders
  • COVID-19 Clinical Research Studies
  • Acute Kidney Injury Research
  • Environmental Sustainability and Education
  • Climate Change and Health Impacts
  • Agricultural and Food Sciences
  • Vasculitis and related conditions
  • Electrolyte and hormonal disorders
  • SARS-CoV-2 and COVID-19 Research
  • Intensive Care Unit Cognitive Disorders
  • Rural Development and Agriculture
  • Disaster Response and Management
  • COVID-19 and healthcare impacts
  • Heparin-Induced Thrombocytopenia and Thrombosis
  • Long-Term Effects of COVID-19

Universidade Estadual Paulista (Unesp)
2020-2024

Universidade de São Paulo
2024

Renal involvement is frequent in COVID-19 (4-37%). This study evaluated the incidence and risk factors of acute kidney injury (AKI) hospitalized patients with COVID-19. Methodology: represents a prospective cohort public tertiary university hospital São Paulo, Brazil, during first 90 days pandemic, followed up until clinical outcome (discharge or death). Results: There were 101 COVID-19, which 51.9% admitted to intensive care unit (ICU). The overall AKI was 50%; 36.8% had hematuria...

10.3389/fmed.2021.622577 article EN cc-by Frontiers in Medicine 2021-02-09

Introduction Elderly patients with COVID-19 are at a higher risk of severity and death as not only several comorbidities but also aging itself has been considered relevant factor. Acute kidney injury (AKI), one the worst complications SARS-CoV-2 infection, is associated worse outcomes. Studies on AKI in Latin-American older age remain scarce. Objectives To determine incidence factors its development, well to compare outcome elderly or without infection Methods This retrospective cohort study...

10.3389/fneph.2022.896891 article EN cc-by Frontiers in Nephrology 2022-05-09

It is acknowledged that Acute Kidney Injury (AKI) multifactorial in COVID-19, as the most relevant factors for its development are cytokine storm, metabolic stress, medication use, rhabdomyolysis, renal viral tropism, and multiple organ dysfunction. However, little known about impact of AKI's pathophysiology on clinical outcome. Our aim to identify pathophysiological mechanisms AKI patients affected by COVID-19 associate them with death.

10.1016/j.ekir.2024.02.055 article EN cc-by-nc-nd Kidney International Reports 2024-04-01

Introduction: COVID-19, caused by the SARS-CoV-2 virus, has been associated with oligosymptomatic cases or severe acute respiratory syndrome, multiple organ failure and death. One of most significant events for clinical outcomes is Acute Kidney Injury (AKI). It known that AKI in COVID-19 multifactorial, main mechanisms are cytokine storm, metabolic stress, use nephrotoxic drugs, rhabdomyolysis, viral tropism to kidney tissues, failure. However, little about impact presentation...

10.3390/covid4080080 article EN cc-by COVID 2024-07-30

Magalhães et al. demonstrated that the incidence of acute kidney injury was high in hospitalized patients with COVID-19 and second wave associated greater severity; however, mortality rates were similar between two periods. This may reflect both effectiveness vaccines constant learning frontline professionals gained throughout pandemic to provide support their patients.

10.31744/einstein_journal/2024ao0687 article EN cc-by Einstein (São Paulo) 2024-01-01

Livro de Memórias do IV SUSTENTARE e VII WIPIS: Workshop internancional Sustentabilidade, Indicadores Gestão Recursos Hídricos (978-85-5722-652-4) - Práticas Sustentáveis Em Indústria Do Agronegócio

10.29327/sustentare_wipis_2022.581599 article PT 2023-01-01

Abstract Cytokine storm syndrome (CSS) has been documented in coronavirus disease 2019 (COVID-19) since the first reports of this disease. In absence vaccines or direct therapy for COVID-19, extracorporeal blood treatment (EBT) could represent an option removal cytokines and may be beneficial to improve clinical outcome critically ill patients. Intermittent haemodialysis (IHD), using high flux (HF) cut-off membranes, continuous renal replacement (CRRT) used purification COVID-19 patients...

10.21203/rs.3.rs-136018/v1 preprint EN cc-by Research Square (Research Square) 2020-12-30

In the absence of direct therapy for COVID-19, extracorporeal blood treatment (EBT) could represent an option cytokine removal.This study aimed to describe and compare removal during intermittent haemodialysis (IHD) continuous renal replacement (CRRT) in COVID-19 patients with Acute Kidney Injury (AKI).It was a cohort that studied COVID-19-related AKI according KDIGO criteria admitted at Intensive Care Unit (ICU). Blood samples were collected start end both IHD using high flux (HF) membranes...

10.2147/ijnrd.s382776 article EN cc-by-nc International Journal of Nephrology and Renovascular Disease 2022-11-01
Coming Soon ...